BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
9/8/2023 9:38:26 AM | Browse: 181 | Download: 512
 |
Received |
|
2023-05-14 10:40 |
 |
Peer-Review Started |
|
2023-05-14 10:42 |
 |
To Make the First Decision |
|
|
 |
Return for Revision |
|
2023-07-17 08:03 |
 |
Revised |
|
2023-07-29 07:07 |
 |
Second Decision |
|
2023-08-14 02:57 |
 |
Accepted by Journal Editor-in-Chief |
|
|
 |
Accepted by Executive Editor-in-Chief |
|
2023-08-15 06:32 |
 |
Articles in Press |
|
2023-08-15 06:32 |
 |
Publication Fee Transferred |
|
|
 |
Edit the Manuscript by Language Editor |
|
|
 |
Typeset the Manuscript |
|
2023-08-30 05:30 |
 |
Publish the Manuscript Online |
|
2023-09-08 09:38 |
ISSN |
2307-8960 (online) |
Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
Copyright |
© The Author(s) 2023. Published by Baishideng Publishing Group Inc. All rights reserved. |
Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
Website |
http://www.wjgnet.com |
Category |
Oncology |
Manuscript Type |
Case Report |
Article Title |
Aggressive variant prostate cancer: A case report and literature review
|
Manuscript Source |
Unsolicited Manuscript |
All Author List |
Xiang-Tao Weng, Wen-Li Lin, Qi-Man Pan, Tao-Fen Chen, Si-Yi Li and Chi-Ming Gu |
ORCID |
|
Funding Agency and Grant Number |
Funding Agency |
Grant Number |
Guangdong Provincial Hospital of Traditional Chinese Medicine |
2022KT1166 and 2018KT1635 |
Guangdong Provincial Bureau of Traditional Chinese Medicine |
2021KT1500 |
Guangzhou Science and Technology Bureau |
202201020350 |
|
Corresponding Author |
Chi-Ming Gu, MD, Chief Physician, Department of Urology, The Second Affiliated Hospital of Guangzhou University of Chinese Medicine, NO. 111 Dade Road, Yuexiu District, Guangzhou 510000, Guangdong Province, China. guchiming@gzucm.edu.cn |
Key Words |
Prostate cancer; Carcinoembryonic antigen; Prostate-specific antigen; Aggressive variant prostate cancer |
Core Tip |
This article reviews the literature and summarizes the characteristics and research progress of the rare clinical subtype, aggressive variant prostate cancer (AVPC), especially the treatment regimen. AVPC has low prostate-specific antigen levels, is hormone refractory, is aggressive, manifests as rare brain and bladder metastases, and has a very poor clinical prognosis. The first-line regimen for AVPC is currently unclear, with platinum-based chemotherapy regimens as the mainstay of intervention at this stage. Liquid biopsy, gene detection and molecular imaging are currently hot research topics that can provide guidance for the clinical treatment of advanced prostate cancer. This report aims to serve as a reference for clinicians. |
Publish Date |
2023-09-08 09:38 |
Citation |
Weng XT, Lin WL, Pan QM, Chen TF, Li SY, Gu CM. Aggressive variant prostate cancer: A case report and literature review. World J Clin Cases 2023; 11(26): 6213-6222 |
URL |
https://www.wjgnet.com/2307-8960/full/v11/i26/6213.htm |
DOI |
https://dx.doi.org/10.12998/wjcc.v11.i26.6213 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345